Showing results (1521-1530 of 1,739) with videos related to
Sort By:
Pageof 174
Physics in Medicine and Biology|August 1, 2014
Integration and evaluation of automated Monte Carlo simulations in the clinical practice of scanned proton and carbon ion beam therapyJ Bauer, F Sommerer, A Mairani, et al.The Journal of Pharmacology and Experimental Therapeutics|August 24, 2014
Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant ratsKathryn E Lillegard, Alex C Loeks-Johnson, Jonathan W Opacich, et al.Analytical Chemistry|May 17, 2024
Absorption Correction for 3D Elemental Distributions of Dental Composite Materials Using Laboratory Confocal Micro-X-ray Fluorescence SpectroscopyLeona J Bauer, Frank Wieder, Vinh Truong, et al.Neurology|March 24, 2004
Rasmussen encephalitis with active inflammation and delayed seizures onsetI Korn-Lubetzki, C G Bien, J Bauer, et al.Practical Radiation Oncology|June 4, 2014
Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastasesDawn Owen, Nadia N Laack, Charles S Mayo, et al.European Journal of Biochemistry|August 17, 1990
The 1H-NMR assignments of the aromatic resonances in complexes of Lactobacillus casei dihydrofolate reductase and the origins of their chemical shiftsB Birdsall, J R Arnold, J Jimenez-Barbero, et al.Cancer Cell International|March 28, 2025
Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapyVerena Schweihofer, Christina Bruss, Stephan Seitz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancerO Pagani, C Sessa, G Martinelli, et al.Journal of the American Chemical Society|August 4, 2007
Length-dependent optical effects in single-wall carbon nanotubesJeffrey A Fagan, Jeffrey R Simpson, Barry J Bauer, et al.British Journal of Cancer|April 1, 2004
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trialR Morant, J Bernhard, D Dietrich, et al.Pageof 174